
FDA aligns with Cognition on a phase 3 zervimesine trial for Lewy body dementia, testing 100 mg daily for 9 months to target hallucinations.
Watch as Glen Gabbard, MD, and his colleagues Holly Crisp-Han, MD, and Gabrielle Hobday, MD, discuss some of the challenges you may face when you are called on to assess another physician. This topic was the focus of a workshop at the APA meeting.
Watch as Glen Gabbard, MD, and his colleagues Holly Crisp-Han, MD, and Gabrielle Hobday, MD, discuss some of the challenges you may face when you are called on to assess another physician. This topic was the focus of a workshop at the APA meeting.






